אוקסליפלטין הוספירה 5 מ"ג/מ"ל - 50 מ"ג

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

OXALIPLATIN 50 MG/VIAL

Tersedia dari:

NOVAPHARMA LTD

Kode ATC:

L01XA03

Bentuk farmasi:

POWDER FOR SOLUTION FOR INFUSION

Rute administrasi :

I.V

Diproduksi oleh:

HOSPIRA AUSTRALIA PTY LTD

Kelompok Terapi:

OXALIPLATIN

Indikasi Terapi:

Oxaliplatin in combination with 5- fluorouracil and folinic acid (FA) is indicated for : - adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour .- treatment of metastatic colorectal cancer.

Tanggal Otorisasi:

2010-01-01